Musculoskeletal manifestations of the antiphospholipid syndrome

Lupus. 2016 Apr;25(5):451-62. doi: 10.1177/0961203316636467. Epub 2016 Feb 27.

Abstract

The scope of clinical and laboratory manifestations of the antiphospholipid syndrome (APS) has increased dramatically since its discovery in 1983, where any organ system can be involved. Musculoskeletal complications are consistently reported in APS patients, not only causing morbidity and mortality, but also affecting their quality of life. We reviewed all English papers on APS involvement in the musculoskeletal system using Google Scholar and Pubmed; all reports are summarized in a table in this review. The spectrum of manifestations includes arthralgia/arthritis, avascular necrosis of bone, bone marrow necrosis, complex regional pain syndrome type-1, muscle infarction, non-traumatic fractures, and osteoporosis. Some of these manifestations were reported in good quality studies, some of which showed an association between aPL-positivity and the occurrence of these manifestations, while others were merely described in case reports.

Keywords: Antiphospholipid syndrome; antibodies; arthralgia; arthritis; avascular necrosis; bone marrow necrosis; complex regional pain syndrome; muscle infarction; non-traumatic fractures; osteoporosis.

Publication types

  • Review

MeSH terms

  • Antibodies, Antiphospholipid / blood
  • Antiphospholipid Syndrome / blood
  • Antiphospholipid Syndrome / complications*
  • Antiphospholipid Syndrome / diagnosis
  • Biomarkers / blood
  • Humans
  • Musculoskeletal Diseases / diagnosis
  • Musculoskeletal Diseases / etiology*
  • Prognosis
  • Risk Factors

Substances

  • Antibodies, Antiphospholipid
  • Biomarkers